EU – Baltic States, Good for Business, Latvia, Railways, Transport
International Internet Magazine. Baltic States news & analytics
Wednesday, 30.04.2025, 05:23
Latvia's DLRR factory's strategy keeps bearing fruit in Q3

![]() |
---|
Photo: dlrr.eu |
"This year, our third-quarter turnover is nearly the same as a year ago, which we see as a positive trend. The strategy to diversify the target markets keeps bearing fruit also this year. Of course, we are feeling an impact from the pandemic, but we are doing all we can to maintain production volumes, largely thanks to expansion to new markets in Europe," said DLRR board member Natalija Petrova.
DLRR representatives indicated that the company's turnover in the third quarter of 2020 was 10.3% higher than in the first six months of this year together.
Of the company's three lines of operations - rolling stock repairs, manufacture of spare parts and metalworking - repair services were currently generating the highest revenue.
In 2019, DLRR generated EUR 38.446 million in turnover, an increase of 31.9% against 2018, while the group's profit was EUR 86,026 in contrast to a loss incurred in 2018, according to information from Firmas.lv.
Estonia's Skinest Rail directly and indirectly holds 7,955,474 shares or 95.92% in DLRR.
- 28.01.2022 BONO aims at a billion!
- 26.08.2021 LLC Dizozols Investments finalizes investment attraction deal with Crowdestor with record-high profits
- 13.02.2021 Моя жизнь в газете. Очерки по новейшей истории Латвии. Глава 1
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer